nach oben

Erschienen in:

08.08.2016 | Original Communication

Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia

verfasst von: Kenji Ishibashi, Yoshiharu Miura, Kinya Ishikawa, Ming-Rong Zhang, Jun Toyohara, Kiichi Ishiwata, Kenji Ishii

Erschienen in: Journal of Neurology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Imaging of type 1 metabotropic glutamate receptor (mGluR1) has recently become possible using positron emission tomography (PET). We aimed to examine the relationship between mGluR1 and cerebellar ataxia. Families with spinocerebellar ataxia type 19/22 (SCA19/22) and SCA6, six patients with sporadic SCA, and 26 healthy subjects underwent PET using an mGluR1 radiotracer. Volumes-of-interest were placed on the anterior and posterior lobes and vermis. The binding potential (BP_ND) was calculated to estimate mGluR1 availability. A partial volume correction was applied to the BP_ND values. The Scale for the Assessment and Rating of Ataxia (SARA) score were measured. In each patient with SCA19/22 and SCA6, the anterior lobe showed the highest decrease rates in the BP_ND values, compared with healthy subjects. In the families with SCA19/22 and SCA6, the disease durations and SARA scores were shorter and lower, respectively, in the offspring, compared with the parents. However, the offspring paradoxically showed lower BP_ND values, especially in the anterior lobe, compared with the parents. The patients with sporadic SCA showed significantly lower BP_ND values in all subregions than healthy subjects. The BP_ND values significantly correlated with the SARA scores in all participants. In conclusion, these results showed a decrease in mGluR1 availability in patients with hereditary and sporadic SCA, a correlation between mGluR1 availability and degree of cerebellar ataxia, and paradoxical findings in two families. These results suggest the potential use of mGluR1 imaging as a specific biomarker of cerebellar ataxia.

Toyohara J, Sakata M, Fujinaga M, Yamasaki T, Oda K, Ishii K, Zhang MR, Moriguchi Jeckel CM, Ishiwata K (2013) Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomography. Nucl Med Biol 40(2):214–220. doi:10.1016/j.nucmedbio.2012.11.008 CrossRefPubMed

Toyohara J, Sakata M, Oda K, Ishii K, Ito K, Hiura M, Fujinaga M, Yamasaki T, Zhang MR, Ishiwata K (2013) Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM. J Nucl Med 54(8):1302–1307. doi:10.2967/jnumed.113.119891 CrossRefPubMed

Martin LJ, Blackstone CD, Huganir RL, Price DL (1992) Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron 9(2):259–270CrossRefPubMed

Shigemoto R, Nakanishi S, Mizuno N (1992) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol 322(1):121–135. doi:10.1002/cne.903220110 CrossRefPubMed

Baude A, Nusser Z, Roberts JD, Mulvihill E, McIlhinney RA, Somogyi P (1993) The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 11(4):771–787CrossRefPubMed

Yamasaki T, Maeda J, Fujinaga M, Nagai Y, Hatori A, Yui J, Xie L, Nengaki N, Zhang MR (2014) PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM, radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate. Am J Nucl Med Mol Imaging 4(3):260–269PubMedPubMedCentral

Yamasaki T, Fujinaga M, Maeda J, Kawamura K, Yui J, Hatori A, Yoshida Y, Nagai Y, Tokunaga M, Higuchi M, Suhara T, Fukumura T, Zhang MR (2012) Imaging for metabotropic glutamate receptor subtype 1 in rat and monkey brains using PET with [18F]FITM. Eur J Nucl Med Mol Imaging 39(4):632–641. doi:10.1007/s00259-011-1995-6 CrossRefPubMed

Li S, Huang Y (2014) In vivo imaging of the metabotropic glutamate receptor 1 (mGluR1) with positron emission tomography: recent advance and perspective. Curr Med Chem 21(1):113–123CrossRefPubMed

Ferraguti F, Crepaldi L, Nicoletti F (2008) Metabotropic glutamate 1 receptor: current concepts and perspectives. Pharmacol Rev 60(4):536–581. doi:10.1124/pr.108.000166 CrossRefPubMed

10.

Aiba A, Kano M, Chen C, Stanton ME, Fox GD, Herrup K, Zwingman TA, Tonegawa S (1994) Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell 79(2):377–388CrossRefPubMed

11.

Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, Henzen-Logmans S, Vecht C, De Zeeuw C, Sekiyama N, Nakanishi S, Shigemoto R (2000) Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 342(1):21–27. doi:10.1056/NEJM200001063420104 CrossRefPubMed

12.

Ichise T, Kano M, Hashimoto K, Yanagihara D, Nakao K, Shigemoto R, Katsuki M, Aiba A (2000) mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination. Science 288(5472):1832–1835CrossRefPubMed

13.

Notartomaso S, Zappulla C, Biagioni F, Cannella M, Bucci D, Mascio G, Scarselli P, Fazio F, Weisz F, Lionetto L, Simmaco M, Gradini R, Battaglia G, Signore M, Puliti A, Nicoletti F (2013) Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. Mol Brain 6:48. doi:10.1186/1756-6606-6-48 CrossRefPubMedPubMedCentral

14.

Ishibashi K, Miura Y, Ishikawa K, Ishii K, Ishiwata K (2015) Decreased metabotropic glutamate receptor type 1 availability in a patient with spinocerebellar ataxia type 6: a (11)C-ITMM PET study. J Neurol Sci 355(1–2):202–205. doi:10.1016/j.jns.2015.05.041 CrossRefPubMed

15.

Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schols L, Szymanski S, van de Warrenburg BP, Durr A, Klockgether T, Fancellu R (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66(11):1717–1720. doi:10.1212/01.wnl.0000219042.60538.92 CrossRefPubMed

16.

Lee YC, Durr A, Majczenko K, Huang YH, Liu YC, Lien CC, Tsai PC, Ichikawa Y, Goto J, Monin ML, Li JZ, Chung MY, Mundwiller E, Shakkottai V, Liu TT, Tesson C, Lu YC, Brice A, Tsuji S, Burmeister M, Stevanin G, Soong BW (2012) Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann Neurol 72(6):859–869. doi:10.1002/ana.23701 CrossRefPubMedPubMedCentral

17.

Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. NeuroImage 4(3 Pt 1):153–158. doi:10.1006/nimg.1996.0066 CrossRefPubMed

18.

Wu Y, Carson RE (2002) Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 22(12):1440–1452. doi:10.1097/00004647-200212000-00004 CrossRef

19.

Meltzer CC, Leal JP, Mayberg HS, Wagner HN Jr, Frost JJ (1990) Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr 14(4):561–570CrossRefPubMed

20.

Raz N, Gunning-Dixon F, Head D, Williamson A, Acker JD (2001) Age and sex differences in the cerebellum and the ventral pons: a prospective MR study of healthy adults. AJNR Am J Neuroradiol 22(6):1161–1167PubMed

21.

Waite LM, Broe GA, Creasey H, Grayson D, Edelbrock D, O’Toole B (1996) Neurological signs, aging, and the neurodegenerative syndromes. Arch Neurol 53(6):498–502CrossRefPubMed

22.

Andersen BB, Gundersen HJ, Pakkenberg B (2003) Aging of the human cerebellum: a stereological study. J Comp Neurol 466(3):356–365. doi:10.1002/cne.10884 CrossRefPubMed

23.

Verbeek DS, Schelhaas JH, Ippel EF, Beemer FA, Pearson PL, Sinke RJ (2002) Identification of a novel SCA locus (SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21. Hum Genet 111(4–5):388–393. doi:10.1007/s00439-002-0782-7 CrossRefPubMed

24.

Schelhaas HJ, Verbeek DS, Van de Warrenburg BP, Sinke RJ (2004) SCA19 and SCA22: evidence for one locus with a worldwide distribution. Brain J Neurol 127 (Pt 1):E6. doi:10.1093/brain/awh036 (author reply E7)

25.

Chung MY, Lu YC, Cheng NC, Soong BW (2003) A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. Brain J Neurol 126(Pt 6):1293–1299CrossRef

26.

Duarri A, Jezierska J, Fokkens M, Meijer M, Schelhaas HJ, den Dunnen WF, van Dijk F, Verschuuren-Bemelmans C, Hageman G, van de Vlies P, Kusters B, van de Warrenburg BP, Kremer B, Wijmenga C, Sinke RJ, Swertz MA, Kampinga HH, Boddeke E, Verbeek DS (2012) Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19. Ann Neurol 72(6):870–880. doi:10.1002/ana.23700 CrossRefPubMed

27.

Seidel K, Kusters B, den Dunnen WF, Bouzrou M, Hageman G, Korf HW, Schelhaas HJ, Verbeek D, Rub U (2014) First patho-anatomical investigation of the brain of a SCA19 patient. Neuropathol Appl Neurobiol 40(5):640–644. doi:10.1111/nan.12128 CrossRefPubMed

28.

Schelhaas HJ, van de Warrenburg BP (2005) Clinical, psychological, and genetic characteristics of spinocerebellar ataxia type 19 (SCA19). Cerebellum 4(1):51–54. doi:10.1080/14734220510007888 CrossRefPubMed

29.

Rub U, Schols L, Paulson H, Auburger G, Kermer P, Jen JC, Seidel K, Korf HW, Deller T (2013) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol 104:38–66. doi:10.1016/j.pneurobio.2013.01.001 CrossRefPubMed

30.

Ishikawa K, Watanabe M, Yoshizawa K, Fujita T, Iwamoto H, Yoshizawa T, Harada K, Nakamagoe K, Komatsuzaki Y, Satoh A, Doi M, Ogata T, Kanazawa I, Shoji S, Mizusawa H (1999) Clinical, neuropathological, and molecular study in two families with spinocerebellar ataxia type 6 (SCA6). J Neurol Neurosurg Psychiatry 67(1):86–89CrossRefPubMedPubMedCentral

31.

Gomez CM, Thompson RM, Gammack JT, Perlman SL, Dobyns WB, Truwit CL, Zee DS, Clark HB, Anderson JH (1997) Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 42(6):933–950. doi:10.1002/ana.410420616 CrossRefPubMed

32.

Kato T, Tanaka F, Yamamoto M, Yosida E, Indo T, Watanabe H, Yoshiwara T, Doyu M, Sobue G (2000) Sisters homozygous for the spinocerebellar ataxia type 6 (SCA6)/CACNA1A gene associated with different clinical phenotypes. Clin Genet 58(1):69–73CrossRefPubMed

33.

Takahashi H, Ishikawa K, Tsutsumi T, Fujigasaki H, Kawata A, Okiyama R, Fujita T, Yoshizawa K, Yamaguchi S, Tomiyasu H, Yoshii F, Mitani K, Shimizu N, Yamazaki M, Miyamoto T, Orimo T, Shoji S, Kitamura K, Mizusawa H (2004) A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6. J Hum Genet 49(5):256–264. doi:10.1007/s10038-004-0142-7 CrossRefPubMed

34.

Klockgether T (2010) Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol 9(1):94–104. doi:10.1016/S1474-4422(09)70305-9 CrossRefPubMed

35.

Stoodley CJ, Schmahmann JD (2009) Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. NeuroImage 44(2):489–501. doi:10.1016/j.neuroimage.2008.08.039 CrossRefPubMed

Titel: Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia
verfasst von: Kenji Ishibashi
Yoshiharu Miura
Kinya Ishikawa
Ming-Rong Zhang
Jun Toyohara
Kiichi Ishiwata
Kenji Ishii
Publikationsdatum: 08.08.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 11/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-016-8248-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2016

Severe axonal neuropathy is a late manifestation of SPG11

Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache

‘De novo’ Col4A2 mutation in a patient with migraine, leukoencephalopathy, and small carotid aneurysms

Łucja Frey (1889–1942)

Long-term follow-up of chronic spinal cord stimulation for medically intractable orthostatic tremor

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie